CDC Rolls Back Newborn Hepatitis B Vaccine Recommendation – STAT News

CDC Reconsiders Newborn Hepatitis B Vaccine: A Sign of Shifting Vaccine Policy? The Centers for Disease Control and Prevention (CDC) recently reversed decades-long guidance, no longer recommending routine hepatitis B vaccination for all newborns. This decision, stemming from a vote by the Advisory Committee on Immunization Practices (ACIP), has sent ripples through the medical community … Read more

Parents, Vaccines & Policy: New Survey Insights

Decoding the Future of Childhood Vaccines: Insights From Parents and Experts <p>Recent surveys reveal a complex landscape of parental views on childhood vaccines. Understanding these perspectives is crucial for navigating the evolving challenges in public health. This article dives into the key findings of a new KFF-Washington Post partnership survey, offering insights into the trends … Read more

West Nile Virus Cases Surge: Up 40% in US During Peak Season

West Nile Virus: What’s Surging, What’s Next, and How to Protect Yourself The West Nile virus is making headlines, and for good reason. Reports indicate an increase in cases, sparking concerns for public health. This isn’t just a seasonal blip; experts are noting unusual intensity. Let’s dive into what’s happening and how you can stay … Read more

Kansas West Nile Virus Cases: 5 Serious

West Nile Virus: Trends and Future Concerns As summer heats up, so does the concern around mosquito-borne illnesses. This article dives into the latest developments in West Nile Virus (WNV), exploring the current situation and what the future might hold. Recent reports highlight the importance of staying informed and taking preventative measures. Current WNV Landscape: … Read more

HFSA and ASPC Release Statement on Shifting to Prevention in Heart Failure

Heart Failure: A Paradigm Shift Towards Prevention and Proactive Care The landscape of heart failure management is undergoing a significant transformation. A recent joint statement by the Heart Failure Society of America (HFSA) and the American Society for Preventive Cardiology (ASPC) underscores a critical shift: moving away from solely treating heart failure to proactively preventing … Read more

6 Endocrinology Headlines You May Have Missed in July 2025

Endocrinology’s Forward March: Key Trends Reshaping Diabetes, CKD, and Growth Hormone Deficiency The field of endocrinology is experiencing a period of unprecedented advancement. From groundbreaking clinical trial results to innovative therapies, the pace of progress in managing conditions like diabetes, chronic kidney disease (CKD), and growth hormone deficiency is accelerating. This article delves into the … Read more

Men With Cirrhosis at Higher Risk for Liver Complications Than Women

Cirrhosis and Sex: Unveiling Disparities and Charting the Course for Future Liver Health Recent research published in JAMA Network Open has brought to light significant sex-based disparities in the outcomes of cirrhosis, a chronic liver disease. This study, and others like it, are crucial for understanding how to tailor treatments and preventive measures to ensure … Read more

Charts: Absenteeism remains high post-pandemic

Massachusetts Schools Grapple with Stubborn Absenteeism: What Does the Future Hold? Chronic absenteeism in Massachusetts schools remains a persistent challenge, casting a shadow on student outcomes and resource allocation. While there has been some progress since the peak of the pandemic, recent data suggests that improvements have stalled, leaving educators and policymakers searching for effective … Read more

Remibrutinib for CSU Treatment

The Future of CSU Treatment: A Look at Oral Therapies and Patient Empowerment Chronic Spontaneous Urticaria (CSU), also known as chronic hives, can significantly impact a patient’s quality of life. Finding effective and convenient treatments is paramount. Recent advancements, particularly in oral therapies like remibrutinib, are reshaping the landscape, offering new hope and opportunities for … Read more

Semaglutide Reduces Progression of PAD by 54% in Type 2 Diabetes

Semaglutide and PAD: Unveiling a Vascular Protective Revolution The medical world is abuzz with the latest findings on semaglutide, particularly its potential to revolutionize the treatment of peripheral artery disease (PAD) in individuals with type 2 diabetes. Recent data from the STRIDE trial, presented at the American Diabetes Association (ADA) Scientific Sessions, suggests the benefits … Read more